ES2031804T3 - Derivado del activador de plasminogeno de tipo tisular. - Google Patents
Derivado del activador de plasminogeno de tipo tisular.Info
- Publication number
- ES2031804T3 ES2031804T3 ES90102329T ES90102329T ES2031804T3 ES 2031804 T3 ES2031804 T3 ES 2031804T3 ES 90102329 T ES90102329 T ES 90102329T ES 90102329 T ES90102329 T ES 90102329T ES 2031804 T3 ES2031804 T3 ES 2031804T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- protein
- sec
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Abstract
EL INVENTO SE REFIERE A UN NUEVO DERIVADO DEL TEJIDO (T-PA) QUE SE EMPLEA ACTIVADOR DE PLASMINOGENO; NO ESTA GLICOSILADO, CONSISTE EN LA SECUENCIA DE AMINOACIDOS DE FORMULA (I); SE CODIFICA A TRAVES DE LA SECUENCIA DNA DE FORMULA (II) Y POSEE BUENAS PROPIEDADES PARA LA DISOLUCION DEL COAGULO DE SANGRE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3903581A DE3903581A1 (de) | 1989-02-07 | 1989-02-07 | Gewebs-plasminogenaktivator-derivat |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2031804T1 ES2031804T1 (es) | 1993-01-01 |
ES2031804T3 true ES2031804T3 (es) | 1995-11-01 |
Family
ID=6373566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90102329T Expired - Lifetime ES2031804T3 (es) | 1989-02-07 | 1990-02-06 | Derivado del activador de plasminogeno de tipo tisular. |
Country Status (29)
Country | Link |
---|---|
US (1) | US5223256A (es) |
EP (1) | EP0382174B1 (es) |
JP (1) | JP2559538B2 (es) |
KR (1) | KR970008485B1 (es) |
AT (1) | ATE126270T1 (es) |
AU (1) | AU623228B2 (es) |
CA (1) | CA2025900C (es) |
CZ (1) | CZ281836B6 (es) |
DD (1) | DD291779A5 (es) |
DE (2) | DE3903581A1 (es) |
DK (1) | DK0382174T3 (es) |
ES (1) | ES2031804T3 (es) |
FI (1) | FI100244B (es) |
GR (2) | GR900300140T1 (es) |
HK (1) | HK153396A (es) |
HU (1) | HU218092B (es) |
IE (1) | IE61077B1 (es) |
IL (1) | IL93280A (es) |
LU (1) | LU90025I2 (es) |
LV (1) | LV10302B (es) |
NL (1) | NL970008I2 (es) |
NO (2) | NO306563B1 (es) |
NZ (1) | NZ232337A (es) |
PT (1) | PT93082B (es) |
RU (1) | RU2107094C1 (es) |
SK (1) | SK55890A3 (es) |
UA (1) | UA27111A1 (es) |
WO (1) | WO1990009437A1 (es) |
ZA (1) | ZA90861B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634007A (en) * | 1985-12-02 | 1987-01-06 | Adolph Coors Company | Carton blank with perforated tear line |
US5676947A (en) * | 1989-02-07 | 1997-10-14 | Boehringer Manneheim Gmbh | Method for treating thromboembolic conditions using thrombolytically active proteins |
DE3923339A1 (de) * | 1989-05-31 | 1990-12-06 | Boehringer Mannheim Gmbh | Gewebs-plasminogen-aktivator-derivat |
GB9019120D0 (en) * | 1990-09-01 | 1990-10-17 | Beecham Group Plc | Novel compounds |
DE4037196A1 (de) * | 1990-11-22 | 1992-05-27 | Boehringer Mannheim Gmbh | Verfahren zur reaktivierung von denaturiertem protein |
DE4123845A1 (de) * | 1991-07-18 | 1993-01-21 | Boehringer Mannheim Gmbh | Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe |
EP0580685B1 (de) * | 1991-04-16 | 1996-01-03 | Roche Diagnostics GmbH | Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe |
US5510330A (en) * | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
DE4423574A1 (de) * | 1994-07-05 | 1996-01-11 | Boehringer Mannheim Gmbh | Nicht-glykosylierte Plasminogenaktivator-Derivate und ihre Verwendung bei erhöhtem Blutungsrisiko |
AU4259496A (en) * | 1994-12-06 | 1996-06-26 | Boehringer Mannheim Gmbh | Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases |
US5723122A (en) * | 1995-06-01 | 1998-03-03 | Boehringer Mannheim Gmbh | Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases |
US6027888A (en) * | 1996-04-05 | 2000-02-22 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells |
US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
BR9811531A (pt) * | 1997-07-23 | 2000-08-22 | Roche Diagnostics Gmbh | Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga |
AU9162198A (en) * | 1997-08-13 | 1999-03-08 | Boehringer Mannheim Gmbh | Plasminogen activator with improved zymogenity |
AU8864398A (en) * | 1997-08-13 | 1999-03-08 | Boehringer Mannheim Gmbh | Plasminogen activator with enhanced zymogenic power and reduced fibrin linking |
DE10105912A1 (de) * | 2001-02-09 | 2002-08-14 | Roche Diagnostics Gmbh | Rekombinante Proteinase K |
DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
TWI482628B (zh) * | 2007-10-18 | 2015-05-01 | Lundbeck & Co As H | 新穎之血栓溶解病患次群 |
EP2289542A1 (en) | 2009-08-31 | 2011-03-02 | PAION Deutschland GmbH | Treatment of neurological or neurodegenerative disorders |
EP2289541A1 (en) | 2009-08-31 | 2011-03-02 | PAION Deutschland GmbH | Treatment of neurological or neurodegenerative disorders |
MA47415A (fr) | 2017-02-03 | 2019-12-11 | Acticor Biotech | Inhibition de l'agrégation plaquettaire à l'aide d'anticorps anti-gpvi humaine |
WO2018210860A1 (en) | 2017-05-16 | 2018-11-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of acute ischemic stroke |
EP3806833A1 (en) | 2018-06-15 | 2021-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of pi3kc2b inhibitors for the preservation of vascular endothelial cell barrier integrity |
WO2021148439A1 (en) | 2020-01-21 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for stimulating cerebrovascular function |
WO2021249974A1 (en) | 2020-06-09 | 2021-12-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fucoidan-functionalized polysaccharide particles with t-pa for targeted thrombolytic therapy |
WO2023156683A1 (en) | 2022-02-21 | 2023-08-24 | Acticor Biotech | Treatment of cardiovascular diseases using anti-human gpvi antibodies |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766075A (en) * | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
DE3382389D1 (de) * | 1982-12-14 | 1991-10-02 | South African Inventions | Plasminogenaktivator. |
US4620948A (en) * | 1982-12-22 | 1986-11-04 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4511502A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
US5073494A (en) * | 1985-04-22 | 1991-12-17 | Genentech, Inc. | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 |
JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
DE3537708A1 (de) * | 1985-10-23 | 1987-04-23 | Boehringer Mannheim Gmbh | Verfahren zur aktivierung von t-pa nach expression in prokaryonten |
US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
US5034225A (en) * | 1985-12-17 | 1991-07-23 | Genentech Inc. | Stabilized human tissue plasminogen activator compositions |
DE3611817A1 (de) * | 1986-04-08 | 1987-10-15 | Boehringer Mannheim Gmbh | Verfahren zur renaturierung von proteinen |
DE3643158A1 (de) * | 1986-04-21 | 1987-11-19 | Boehringer Mannheim Gmbh | Gewebs-plasminogen-aktivator(tpa) - derivat und seine herstellung |
US4898825A (en) * | 1986-05-07 | 1990-02-06 | Mitsui Toatsu Chemicals, Incorporated | Methods for purification of single-chain and double-chain tissue plasminogen activator |
JPH0779692B2 (ja) * | 1986-05-07 | 1995-08-30 | 三井東圧化学株式会社 | 一本鎖t−PAと二本鎖t−PAを分離する方法 |
JPS6463378A (en) * | 1986-08-11 | 1989-03-09 | Mitsui Toatsu Chemicals | Separation of single stranded tpa and double standard tpa |
SE8702562L (sv) * | 1987-06-18 | 1988-12-19 | Kabigen Ab | Nya fibrinolytiska enzymer |
US4935237A (en) * | 1988-03-21 | 1990-06-19 | Genentech, Inc. | Processes for the preparation of t-PA mutants |
IL87276A (en) * | 1987-08-03 | 1995-07-31 | Fujisawa Pharmaceutical Co | Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it |
US5037752A (en) * | 1987-10-09 | 1991-08-06 | Monsanto Company | Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277 |
US4963357A (en) * | 1987-10-09 | 1990-10-16 | Monsanto Company | Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor |
-
1989
- 1989-02-07 DE DE3903581A patent/DE3903581A1/de not_active Withdrawn
-
1990
- 1990-01-30 IE IE34390A patent/IE61077B1/en not_active IP Right Cessation
- 1990-02-01 NZ NZ232337A patent/NZ232337A/xx unknown
- 1990-02-02 DD DD90337557A patent/DD291779A5/de not_active IP Right Cessation
- 1990-02-05 IL IL9328090A patent/IL93280A/en not_active IP Right Cessation
- 1990-02-06 LU LU90025C patent/LU90025I2/fr unknown
- 1990-02-06 RU SU4831496A patent/RU2107094C1/ru active
- 1990-02-06 CZ CS90558A patent/CZ281836B6/cs not_active IP Right Cessation
- 1990-02-06 ZA ZA90861A patent/ZA90861B/xx unknown
- 1990-02-06 DK DK90102329.1T patent/DK0382174T3/da active
- 1990-02-06 KR KR1019900702203A patent/KR970008485B1/ko not_active IP Right Cessation
- 1990-02-06 US US07/585,129 patent/US5223256A/en not_active Expired - Lifetime
- 1990-02-06 JP JP2502957A patent/JP2559538B2/ja not_active Expired - Lifetime
- 1990-02-06 AU AU50470/90A patent/AU623228B2/en not_active Expired
- 1990-02-06 AT AT90102329T patent/ATE126270T1/de active
- 1990-02-06 UA UA4831496A patent/UA27111A1/uk unknown
- 1990-02-06 WO PCT/EP1990/000194 patent/WO1990009437A1/de active IP Right Grant
- 1990-02-06 SK SK558-90A patent/SK55890A3/sk not_active IP Right Cessation
- 1990-02-06 HU HU644/90A patent/HU218092B/hu unknown
- 1990-02-06 DE DE59009487T patent/DE59009487D1/de not_active Expired - Lifetime
- 1990-02-06 EP EP90102329A patent/EP0382174B1/de not_active Expired - Lifetime
- 1990-02-06 CA CA002025900A patent/CA2025900C/en not_active Expired - Lifetime
- 1990-02-06 ES ES90102329T patent/ES2031804T3/es not_active Expired - Lifetime
- 1990-02-07 PT PT93082A patent/PT93082B/pt not_active IP Right Cessation
- 1990-09-27 NO NO904211A patent/NO306563B1/no not_active IP Right Cessation
- 1990-10-08 FI FI904951A patent/FI100244B/fi active IP Right Grant
-
1991
- 1991-09-27 GR GR90300140T patent/GR900300140T1/el unknown
-
1993
- 1993-06-01 LV LVP-93-448A patent/LV10302B/xx unknown
-
1995
- 1995-08-10 GR GR950402065T patent/GR3017099T3/el unknown
-
1996
- 1996-08-08 HK HK153396A patent/HK153396A/xx not_active IP Right Cessation
-
1997
- 1997-02-17 NL NL970008C patent/NL970008I2/nl unknown
-
2000
- 2000-05-19 NO NO2000002C patent/NO2000002I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2031804T3 (es) | Derivado del activador de plasminogeno de tipo tisular. | |
DE69027989D1 (de) | Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON | |
DK288183A (da) | Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel | |
KR890007750A (ko) | 인간 조직 인자 억제제의 dna 클론 | |
ES2138973T3 (es) | Muteinas de il-6 exentas de cisteina. | |
ES2108694T3 (es) | Inhibidor de proteasa. | |
NO913129L (no) | Nytt trombolytisk middel. | |
ATE111525T1 (de) | Plasminogenaktivator-varianten und verfahren zu ihrer herstellung. | |
DE69002946D1 (de) | Paracetamol enthaltende arzneizubereitung. | |
CA2004764A1 (en) | Ancrod proteins, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 382174 Country of ref document: ES |